COVID-19 and pulmonary arterial hypertension (PAH) may share molecular mechanisms that could explain common disease-related features, a study reported. According to researchers, the findings provide a framework for exploring disease mechanisms and prioritizing future therapeutic strategies that target overlapping mechanisms of both conditions. The study, “Network-Based Multiomics Integration…
Discussion
People with pulmonary arterial hypertension (PAH) have less diversity among the viruses that infect bacteria in their digestive tracts, according to a new study. These findings add to a growing body of research suggesting that the gut microbiome — the community of bacteria, viruses, and other microscopic organisms…
Discussion
Once-daily use of Insmed‘s experimental inhaled treatment TPIP — fully, treprostinil palmitil inhalation powder — showed a range of benefits over one year in people with pulmonary arterial hypertension (PAH), a rare condition in which the blood vessels supplying the lungs become narrowed. That’s according to new 12-month…
Discussion
In May, I wrote about my optimistic plan to help care for my mother after a minor surgery. We were keeping our fingers crossed, hoping for only minor complications for both of us during the upcoming weeks. Unfortunately, that’s not how things turned out. In fact, the hit of…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
